Case Report
In the current episode, his blood counts and sugar levels -both fasting and postprandial -were normal, and tests for human immunodeficiency virus (HIV) conducted after pretest counseling were nonreactive to HIV 1 and 2. Chest radiograph posterior-anterior view showed cavities in the left upper and middle zones and fibrosis on the right upper zone. His sputum smears were positive for acid-fast bacilli [ Figure 1 ].
Because of his recurrent infections and the underlying cavitary lesions, there was a strong suspicion of atypical mycobacterial infection. [2] His sputum sent for liquid culture for Mycobacterium tuberculosis by MGIT showed no growth at the end of 6 weeks. At the same time, a sputum sample was also sent for NTM diagnosis using BACTEC MGIT 960 TB system by rapid detection and continuous monitoring using fluorescence method. Slow-growing NTM were identified at 7 weeks of incubation. GenoType ® Mycobacterium Improved molecular diagnostic techniques have resulted in increased reporting of nontuberculous mycobacterial infections. A 40-year-old male immunocompetent individual presented with cough and fever of 2-week duration. His chest X-ray showed cavities in the left upper zone and fibrosis in the right upper zone. His sputum was positive for AFB on Ziehl-Neelsen staining and showed slow-growing mycobacteria in mycobacteria growth indicator tube. The isolate was identified as Mycobacterium interjectum using GenoType ® Mycobacterium CM assay (Hain Lifescience, GmBH, Nehren, Germany). At the end of a year's treatment, this first case from India has shown good progress.
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First report from India, immunocompetent individual, Mycobacterium interjectum, pulmonary infection, slow-growing mycobacteria CM -Line Probe Molecular ID NTM identified the isolate as M. interjectum. Antimicrobial susceptible testing could not be performed. A regimen consisting of rifampicin, ethambutol, and levofloxacin in weight-adjusted doses was initiated. At the end of 1 year, he has improved symptomatically, has negative smears, and has radiological improvement [ Figure 2 ].
Although currently there is no respiratory disability, his lung perfusion scan performed with 3-5 mCi 99m Tc-macro aggregated albumin shows reduced lung volumes of around 85% and 15% in the left and right lung, respectively. Correspondingly, there is a marked reduction in the forced vital capacity (41% predicted) and forced expiratory volume (24% predicted).
The patient is proposed to be enlisted in a pulmonary rehabilitation program. dIscussIon M. interjectum is a very poorly growing species, and its classification is based on unique base sequences in the 16S ribosomal RNA. [3] Infection with M. interjectum was first described by Springer et al. in 1993 in a child with cervical lymphadenitis. [1] Since then, only 19 cases have been described in world literature (9 in children aged 1-3 years and 10 in adults).
M. interjectum usually presents as lymphadenitis. [4, 5] Only five adult cases of lung involvement are reported: [5] [6] [7] [8] [9] four in nonimmunocompromised individuals including one presenting as a new case [7] and one where the status was not described. [5] Four of these cases had cavitary lesions as in the case under report.
As per the American Thoracic Society guidelines, [10] clinical, radiological, and microbiologic criteria are equally important and have to be met to diagnose NTM lung disease. Microbiologic criteria include examination of three or more specimens for analysis. Although we met the clinical and radiological criteria of the guidelines, due to resource constraints, we could perform the sputum analysis only once as described.
It is known that the organism has variability in susceptibility to different drugs and treatment should be guided by drug-susceptibility testing (DST). Due to limited resources and infrequently available accredited laboratories which carry out DST for NTM in India, we could not do DST but initiated treatment in consultation with the microbiologist. The progress so far has been satisfactory except for the decreased respiratory functions which are known to occur in a majority of cases in India, post treatment completion. [11] Our case had recurrent episodes of pulmonary TB which were investigated by sputum smears only and responded to first-line anti-TB treatment. Culture for M. tuberculosis was negative at a previous episode as also in the current one. In the present episode, the isolate was identified as M. interjectum using newer molecular technique. conclusIon This is the first case of cavitary pulmonary infection in an immunocompetent individual from India, where M. interjectum was isolated using molecular techniques. 
